Skip to main content

Brockstedt Dirk G.'s Form 4 filing

RAPT Therapeutics, Inc. (RAPT) · filed Apr 12, 2022

Accession no.
0001593968-22-000858
Filed
Apr 12, 2022
Trade date
Apr 11, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market sales total $61.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Brockstedt Dirk G.CIK 0001635616Officer (Chief Scientific Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 11, 2022Common StockMOption exerciseAcquired+2,647$6.18+$16,358.4622,459Direct
Apr 11, 2022Common StockSSaleDisposed−2,647$23.05−$61,013.3519,812Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 11, 2022Common StockMOption exerciseDisposed−1,290$0.00$02,113Direct
Apr 11, 2022Common StockMOption exerciseDisposed−1,357$0.00$015,690Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)